Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/anyaivanova

Bacteria discovered in Cork improves ability to cope with stress

The bacteria is being developed for a microbacterial and vitamin supplement.

A STRAIN OF bacteria first discovered by researchers at University College Cork appears to improve people’s ability to cope with stress.

The snappily named B. longum 1714 was discovered at UCC’s APC Microbiome Institute. It’s from the family of bacteria that are given to a baby from its mother at birth.

Now a major international study has shown that it helps people manage stress by changing how the brain processes stress stimuli.

The study was carried out by the Department of Psychosomatic Medicine and Psychotherapy at the University Hospital of Tübingenin in Germany. 

As part of the four-week trial 40 participants played the notoriously stressful Cyberball game which saw them virtually tossing balls with two other virtual players.

Each of the participants was given a dose of the bacteria or a placebo each day. They experienced heightened stress during the games but those who were given the probiotic were found to be able to manage their stress better.

Over the course of the trial period the bacteria was found to improve how their brain deals with stressful events and moderate brain processes that are linked to negative emotions.

The study supports what research on animals has shown for a long time.

The researchers said they were sceptical about the claims made about probiotics and the gut-brain axis but their comprehensive study provided “novel and innovative” results which provide a basis to assess the “true impact of specific bacterial strains on the brain”.

The bacteria are being developed by Alimentary Healthcare for a microbacterial and vitamin supplement.

“We are delighted with these results, which show the potential for targeted strains with a scientific basis to support claims,” the company’s CEO, Dr Barry Kiely, said.

The study has been published in the American Journal of Gastroenterology.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
16 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds